欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Escherichia coli O17:K52:H18 50S ribosomal protein L30 (rpmD) CSB-YP484614EOG
CSB-EP484614EOG
CSB-BP484614EOG
CSB-MP484614EOG
CSB-EP484614EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 50S ribosomal protein L24 (rplX) CSB-YP484615EOG
CSB-EP484615EOG
CSB-BP484615EOG
CSB-MP484615EOG
CSB-EP484615EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 30S ribosomal protein S3 (rpsC) CSB-YP484616EOG
CSB-EP484616EOG
CSB-BP484616EOG
CSB-MP484616EOG
CSB-EP484616EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Protein TusC (tusC) CSB-YP484617EOG
CSB-EP484617EOG
CSB-BP484617EOG
CSB-MP484617EOG
CSB-EP484617EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 3-dehydroquinate synthase (aroB) CSB-YP484618EOG
CSB-EP484618EOG
CSB-BP484618EOG
CSB-MP484618EOG
CSB-EP484618EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Pimelyl-[acyl-carrier protein] methyl ester esterase (bioH) CSB-YP484619EOG
CSB-EP484619EOG
CSB-BP484619EOG
CSB-MP484619EOG
CSB-EP484619EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Glyoxylate/hydroxypyruvate reductase B (ghrB) CSB-YP484620EOG
CSB-EP484620EOG
CSB-BP484620EOG
CSB-MP484620EOG
CSB-EP484620EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 L-lactate dehydrogenase [cytochrome] (lldD) CSB-YP484621EOG
CSB-EP484621EOG
CSB-BP484621EOG
CSB-MP484621EOG
CSB-EP484621EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 UPF0758 protein yicR (yicR) CSB-YP484622EOG
CSB-EP484622EOG
CSB-BP484622EOG
CSB-MP484622EOG
CSB-EP484622EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Putative transport protein YidE (yidE), partial CSB-YP484623EOG
CSB-EP484623EOG
CSB-BP484623EOG
CSB-MP484623EOG
CSB-EP484623EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Ribonuclease P protein component (rnpA) CSB-YP484624EOG
CSB-EP484624EOG
CSB-BP484624EOG
CSB-MP484624EOG
CSB-EP484624EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (mnmG) CSB-YP484625EOG
CSB-EP484625EOG
CSB-BP484625EOG
CSB-MP484625EOG
CSB-EP484625EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Dihydroxy-acid dehydratase (ilvD) CSB-YP484626EOG
CSB-EP484626EOG
CSB-BP484626EOG
CSB-MP484626EOG
CSB-EP484626EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Fatty acid oxidation complex subunit alpha (fadB) CSB-YP484627EOG
CSB-EP484627EOG
CSB-BP484627EOG
CSB-MP484627EOG
CSB-EP484627EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 L-rhamnose mutarotase (rhaM) CSB-YP484628EOG
CSB-EP484628EOG
CSB-BP484628EOG
CSB-MP484628EOG
CSB-EP484628EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 ATP-dependent protease ATPase subunit HslU (hslU) CSB-YP484629EOG
CSB-EP484629EOG
CSB-BP484629EOG
CSB-MP484629EOG
CSB-EP484629EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 50S ribosomal protein L11 (rplK) CSB-YP484630EOG
CSB-EP484630EOG
CSB-BP484630EOG
CSB-MP484630EOG
CSB-EP484630EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Regulator of sigma D (rsd) CSB-YP484631EOG
CSB-EP484631EOG
CSB-BP484631EOG
CSB-MP484631EOG
CSB-EP484631EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Peptidase E (pepE) CSB-YP484632EOG
CSB-EP484632EOG
CSB-BP484632EOG
CSB-MP484632EOG
CSB-EP484632EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 LexA repressor (lexA) CSB-YP484633EOG
CSB-EP484633EOG
CSB-BP484633EOG
CSB-MP484633EOG
CSB-EP484633EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.practicalworld.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×